Design considerations of an IL13Rα2 antibody–drug conjugate for diffuse intrinsic pontine glioma
Xiaolei Lian(Children's Cancer Therapy Development Institute), Noah Berlow(Children's Cancer Therapy Development Institute)
Cited by 40
Related Papers
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
|BMC Cancer|2019|19
Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma
|Molecular Case Studies|2021|0